학술논문

SOX2 dosage sustains tumor-promoting inflammation to drive disease aggressiveness by modulating the FOSL2/IL6 axis
Document Type
Journal
Source
MOLECULAR CANCER; MAR 17 2023, 22 1, p52 12p.
Subject
Language
English
ISSN
14764598